Initial use of adjuvants is low among cancer patients, study finds

10/4/2012 | MedWire News (U.K.)

In a study of more than 200 cancer patients, fewer than one-third initially received an adjuvant medication, although a larger number of people were given one over the following two weeks as they continued to assess their pain, Italian researchers told a European oncology conference. Researcher Dr. Sandro Barni said the study shows cancer patients need to be followed closely and treatments should be adjusted based on pain scales.

View Full Article in:

MedWire News (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Principal Engineer - Service (US/MI/00/0043/SL) - 14000009CP
Abbott
Chicago, IL
Senior Manager, Compliance
Stryker
Fremont, CA
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA